CA
NZ
UK
AU
IND
US
Director Elisabeth B. Donohue filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 120 shares of NRG Energy, Inc. common stock on November 2, 2026, at a price of $0 per share.
Director Marcie Zlotnik of NRG Energy, Inc. filed a statement of changes in beneficial ownership on November 4, 2026, disclosing an acquisition of 43 shares of NRG common stock on November 2, 2026, at a price of $0 per share through accrued dividend equivalent …
Director Sanjay Kapoor filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 19 shares of NRG Energy, Inc. common stock on November 2, 2026, at a price of $0, representing dividend equivalent rights accrued on deferred or restricted …
Director Alexander J. Pourbaix filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 64 shares of NRG Energy, Inc. common stock on November 2, 2026, at no cost through accrued dividend equivalent rights.
Brian Curci, Executive Vice President and General Counsel of NRG Energy, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, reporting the acquisition of 66 shares of NRG common stock on November 2, 2026.
Director Alexandra Pruner filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 164 shares of NRG Energy, Inc. common stock on November 2, 2026, at no cost, in connection with dividend equivalent rights on deferred or restricted stock …
Robert J. Gaudette, President and Chief Executive Officer and a Director of NRG Energy, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing an acquisition of common stock on November 2, 2026.
Dak Liyanearachchi, Executive Vice President and Chief Technology Officer of NRG Energy, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing a transaction dated November 2, 2026.
Matthew Pistner, Executive Vice President and President of NRG Wholesale at NRG Energy, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, reporting a transaction dated November 2, 2026.
OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC jointly filed a statement of changes in beneficial ownership with the SEC on November 4, 2026, reporting transactions in Aspen Neuroscience, Inc. common stock dated November 2, 2026, in connection with the company's initial public …
Please wait processing your request...